Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures

Israel Medical Association Journal

Volumn 4, Issue 1, 2002, Pages 7-12

  Abedat, Suzan ^a   Urieli Shoval, Simcha ^a   Shapira, Eli ^a   Calko, Sima ^a   Ben Chetrit, Eldad ^a   Matzner, Yaacov ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

C5a inhibitor; Familial Mediterranean fever; MEFV

Indexed keywords

DISEASES; PATIENT TREATMENT; TISSUE;

FIBROBLAST CULTURES;

BIOMEDICAL ENGINEERING;

ALPHA INTERFERON; BETA ACTIN; COLCHICINE; COMPLEMENT COMPONENT C5A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PROTEIN; PROTEIN MEFV; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FAMILIAL MEDITERRANEAN FEVER; FIBROBLAST CULTURE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; NEUTROPHIL; PERITONEUM; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROSA; SYNOVIAL FLUID;

ANTINEOPLASTIC AGENTS; COLCHICINE; COMPLEMENT INACTIVATOR PROTEINS; CYTOKINES; FAMILIAL MEDITERRANEAN FEVER; FIBROBLASTS; GENE EXPRESSION; GOUT SUPPRESSANTS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-1; NEUTROPHILS; PERITONEUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036184889     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Familial Mediterranean fever. A survey of 470 cases and review of the literature
2. A C5a inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever
3. Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever
4. Proposed mechanism of the inflammatory attacks in familial Mediterranean fever
5. A chemotactic inhibitor in synovial fluid
6. A C5a inhibitor in peritoneal fluid
7. Partial characterization of a C5a inhibitor in peritoneal fluid
8. Inactivation of interleukin-8 by the C5a inactivating protease from serosal fluid
9. Production of C5a antagonist by synovial and peritoneal tissue fibroblasts
10. Purification and characterization of a C5a inactivating enzyme from human peritoneal fluid
11. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures
12. A candidate gene for familial Mediterranean fever
13. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever
14. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin
15. The familial Mediterranean fever protein interacts and colocalizes with putative Golgi transporter
16. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators
17. Familial Mediterranean fever
18. The hereditary periodic fever syndromes: Molecular analysis of a new family of inflammatory diseases
19. B30.2-like domain proteins: Update and new insights into a rapidly expanding family of proteins
20. RING fingers and B-boxes: Zinc-binding protein-protein interaction domains
21. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever
22. Colchicine therapy for familial Mediterranean fever: A double-blind trial
23. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: A pilot study
24. Hypothesis: Familial Mediterranean fever - A genetic disorder of the lipocortin family?
25. Induced TNF production in vitro as a test for familial Mediterranean fever